Drugs Controller General of India (DCGI) has granted permission to Cipla to import Moderna’s Covid-19 vaccine for restricted emergency use in the country as per the provisions of the New Drugs and Clinical Trial Rules. Moderna informed DCGI that the US government has agreed to donate a certain number of doses of its Covid-19 vaccine through COVAX to India for use here and sought approval from the Central Drugs Standard Control Organisation (CDSCO) for the vaccines.
Zydus Cadila Covid-19 vaccine for children above 12 years is expected to be available by August as its trials are likely to be completed by July-end, “Trial will be almost complete till July-end and in August, we will be able to vaccinate children aged between 12-18 years”.
Serum Institute of India has started the production of the first batch of Novavax(known as Covovax in India) covid vaccine. Serum Institute of India (SII) CEO Adar Poonawalla in a tweet said the Novavax vaccine has “great potential to protect our future generations below the age of 18. Trials are ongoing.” US-based Novavax Inc has a vaccine manufacturing agreement with Serum Institute of India.
At a press conference on behalf of the Union Health Ministry, Dr. Balram Bhargava, Director-General of the Indian Council of Medical Research (ICMR), stated, “The Ministry of Health has issued guidelines allowing the vaccine to be given to pregnant women. The vaccine is beneficial to pregnant women and should be administered.”
COVID-19 vaccine exports has been that it would depend on its domestic needs and asserted that right now the priority remains utilising made-in-India jabs for its own inoculation drive. Moreover, the issue of vaccine exports has been consistent and clear. We have always stated that overseas supply of vaccines from India would depend on vaccine availability and our domestic vaccination programme.
Allocation of COVID-19 vaccines to a state is done based on its population, caseload, utilisation efficiency and wastage factors, the Union Health Ministry. Information about the vaccine supply by the Government of India, consumption by the states and union territories, balance and unutilised vaccine doses available with them, along with vaccine supply in the pipeline is regularly shared through press releases made by Press Information Bureau (PIB).
One of the nine identity cards, including Aadhaar, Electors Photo Identity Card (EPIC), ration card with photo and disability ID card, is required for availing of vaccination, special provisions have been made by Central Government for organising vaccination sessions for those who may not have any of the nine specified identity cards or own a mobile phone. The Union government had issued an advisory for near-to-home vaccination centre services for the elderly and those with disability. Moreover those who may not have access to the Internet or a smart phone or even to a mobile phone, free of cost on-site registration (popularly called walk-in) and vaccination were available at all government vaccination centers.
46 per cent of the people who received the vaccine yesterday were women and 53 per cent were men. We have to work on this imbalance, create awareness among women and bring them forward. The Health Ministry also rubbished reports alleging non-supply of free vaccines for 18+ group by the Delhi government and said that the Government of India (GoI) has ensured that full supplies of vaccines under direct state procurement are provided to states before June 21.
India administered a record 8.5 million doses of covid-19 vaccines on the first day of a new phase of vaccination. The previous record was achieved in early April at 4.3 million doses. Earlier this month, the government said India could have as many as 10 million doses of covid-19 vaccines available per day in July and August.